Crizotinib in Combination With Chemotherapy for Pediatric Patients With ALK+ Anaplastic Large-Cell Lymphoma: The Results of Children's Oncology Group Trial ANHL12P1 In a 20-year retrospective cohort ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback